We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
ANI Pharmaceuticals
ANIP
$1.77B
| $17.4K | ﹤0.01% |
210
+14
| +7% | +$1.12K |
|
2002
Winmark
WINA
$1.19B
| $17.3K | ﹤0.01% |
41
-5
| -11% | -$1.96K |
|
|
CLDT
2003
Chatham Lodging
CLDT
$630M
| $17.3K | ﹤0.01% |
1,311
| – | – |
|
2004
DraftKings
DKNG
$11.4B
| $17.3K | ﹤0.01% |
685
+159
| +30% | +$3.92K |
|
|
TLN
2005
Talen Energy Corp
TLN
$17.2B
| $17.3K | ﹤0.01% |
45
-9
| -17% | -$3.3K |
|
2006
CryoPort
CYRX
$775M
| $17.3K | ﹤0.01% |
1,099
| – | – |
|
2007
Great Southern Bancorp
GSBC
$863M
| $17.3K | ﹤0.01% |
220
| – | – |
|
2008
United Bankshares
UBSI
$6.55B
| $17.2K | ﹤0.01% |
376
| – | – |
|
2009
Mercantile Bank Corp
MBWM
$1.01B
| $17.2K | ﹤0.01% |
300
| – | – |
|
2010
Zeta Global
ZETA
$4.77B
| $17K | ﹤0.01% |
865
+326
| +60% | +$6.05K |
|
2011
Bowman Consulting
BWMN
$454M
| $17K | ﹤0.01% |
582
+72
| +14% | +$2.27K |
|
2012
Schwab Fundamental US Large Company Index ETF
FNDX
$26.4B
| $17K | ﹤0.01% |
+546
| New | +$16.5K |
|
2013
Shake Shack
SHAK
$2.3B
| $17K | ﹤0.01% |
303
+298
| +5,960% | +$22.4K |
|
2014
Kadant
KAI
$3.69B
| $17K | ﹤0.01% |
54
+2
| +4% | +$623 |
|
2015
Dentsply Sirona
XRAY
$2.59B
| $16.9K | ﹤0.01% |
1,590
-283
| -15% | -$3.09K |
|
|
FLG
2016
Flagstar Bank National Association
FLG
$5.77B
| $16.9K | ﹤0.01% |
1,128
+443
| +65% | +$6.28K |
|
2017
Kinsale Capital Group
KNSL
$7.95B
| $16.8K | ﹤0.01% |
51
-13
| -20% | -$4.18K |
|
|
AMBQ
2018
Ambiq Micro
AMBQ
$1.7B
| $16.8K | ﹤0.01% |
+190
| New | +$11.3K |
|
2019
Arlo Technologies
ARLO
$1.4B
| $16.8K | ﹤0.01% |
1,244
| – | – |
|
2020
Cars.com
CARS
$641M
| $16.7K | ﹤0.01% |
1,530
+373
| +32% | +$3.79K |
|
2021
Graco
GGG
$12.9B
| $16.7K | ﹤0.01% |
221
-3,346
| -94% | -$264K |
|
|
ECHO
2022
EchoStar
ECHO
$25.5B
| $16.6K | ﹤0.01% |
164
-6
| -4% | -$733 |
|
2023
Super Micro Computer
SMCI
$19.5B
| $16.6K | ﹤0.01% |
567
-777
| -58% | -$24.8K |
|
|
FSUN
2024
FirstSun Capital Bancorp
FSUN
$1.61B
| $16.6K | ﹤0.01% |
428
+153
| +56% | +$5.6K |
|
2025
LXP Industrial Trust
LXP
$3.53B
| $16.6K | ﹤0.01% |
308
| – | – |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.